
CellaVision
196
SEK
-0,1 %
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1.491 følger denne virksomhed
-0,1%
-3,92%
-9,89%
-17,99%
-22,38%
-22,99%
-40,28%
-41,23%
+1.156,41%
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Læs mereMarkedsværdi
4,67 mia. SEK
Aktieomsætning
2,55 mio. SEK
Omsætning
723,22 mio.
EBIT %
24,57 %
P/E
33,22
Udbytteafkast, %
1,15 %
Finanskalender
29.4
2025
Delårsrapport Q1'25
6.5
2025
Generalforsamling '25
7.5
2025
Årligt udbytte
ViserAlle indholdstyper

Mixed Regional Performance Sales Peak in APAC
Modular Finance IR Consensus: CellaVision – Consensus estimates Q4 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Invitation to Presentation of the CellaVision Year-end Report for 2024 on February 6, at 11:00 CET
Nomination Committee for the CellaVision Annual General Meeting 2025
Redeye: Cellavision Q3’2024 - Underlying momentum intact

CellaVision, Audiocast with teleconference, Q3'24
Strong Sales in EMEA Amid Market Uncertainties in the US
Invitation to Presentation of the CellaVision Report for the Third Quarter 2024 on October 24, at 11:00 CEST
Redeye: Cellavision Q2 - Mostly in line with some minor issues

CellaVision, Audiocast with teleconference, Q2'24
Solid Quarter and Growth in APAC
Invitation to Presentation of the CellaVision Report for the Second Quarter 2024 on July 19, at 11:00 CEST
Bulletin from the Annual General Meeting of CellaVision AB (publ)
Redeye: Cellavision - Trend is still their friend
